Details for New Drug Application (NDA): 019281
✉ Email this page to a colleague
The generic ingredient in CYKLOKAPRON is tranexamic acid. There are eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 019281
Tradename: | CYKLOKAPRON |
Applicant: | Pfizer |
Ingredient: | tranexamic acid |
Patents: | 0 |
Pharmacology for NDA: 019281
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 019281
Suppliers and Packaging for NDA: 019281
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYKLOKAPRON | tranexamic acid | INJECTABLE;INJECTION | 019281 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-1114 | 0013-1114-15 | 1 AMPULE in 1 CARTON (0013-1114-15) / 10 mL in 1 AMPULE (0013-1114-01) |
CYKLOKAPRON | tranexamic acid | INJECTABLE;INJECTION | 019281 | NDA | Pfizer Laboratories Div Pfizer Inc | 0013-1114 | 0013-1114-21 | 10 VIAL in 1 BOX (0013-1114-21) / 10 mL in 1 VIAL (0013-1114-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
Approval Date: | Dec 30, 1986 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 019281
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CYKLOKAPRON | tranexamic acid | INJECTABLE;INJECTION | 019281-001 | Dec 30, 1986 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription